We are live on
!
Find out more
Two Sigma Advisers Portfolio holdings
AUM
$51.4B
1-Year Est. Return
31.07%
This Fund
S&P 500
This Quarter
Est. Return
+0.38%
1 Year Est. Return
+31.07%
3 Year Est. Return
+128.94%
5 Year Est. Return
+161.75%
10 Year Est. Return
+607.06%
AUM
$40.9B
AUM Growth
+$673M
(+1.7%)
Cap. Flow
+$1.28B
Cap. Flow
% of AUM
3.14%
Top 10 Holdings %
Top 10 Hldgs %
11.68%
Holding
2,544
New
250
Increased
806
Reduced
1,116
Closed
346
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$292M |
| 2 |
Cisco
CSCO
|
+$289M |
| 3 |
Microsoft
MSFT
|
+$289M |
| 4 |
Lowe's Companies
LOW
|
+$262M |
| 5 |
Visa
V
|
+$252M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amgen
AMGN
|
+$317M |
| 2 |
ATVI
Activision Blizzard
ATVI
|
+$240M |
| 3 |
Dollar Tree
DLTR
|
+$163M |
| 4 |
Wayfair
W
|
+$150M |
| 5 |
Ulta Beauty
ULTA
|
+$143M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.69% |
| 2 | Consumer Discretionary | 15.78% |
| 3 | Healthcare | 14.42% |
| 4 | Industrials | 10.75% |
| 5 | Financials | 8.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
NovoCure
NVCR
$1.91B
| $66.9M | 0.16% |
894,500
+282,200
| +46% | +$22.6M |
|
152
Neurocrine Biosciences
NBIX
$16.6B
| $66M | 0.16% |
732,973
-66,300
| -8% | -$6.19M |
|
153
Huntsman Corp
HUN
$1.77B
| $65.4M | 0.16% |
2,811,178
-128,100
| -4% | -$2.65M |
|
154
Darden Restaurants
DRI
$24.4B
| $65M | 0.16% |
549,796
-345,839
| -39% | -$42.2M |
|
|
CELG
155
DELISTED
Celgene Corp
CELG
| $64M | 0.16% |
644,726
-1,018,400
| -61% | -$96.8M |
|
156
Planet Fitness
PLNT
$3.96B
| $63.4M | 0.16% |
1,095,100
-234,800
| -18% | -$16.5M |
|
157
Marriott International
MAR
$92.3B
| $63.3M | 0.16% |
509,153
+450,785
| +772% | +$59.8M |
|
158
CF Industries
CF
$17.3B
| $62.9M | 0.15% |
1,278,490
+36,200
| +3% | +$1.75M |
|
159
C.H. Robinson
CHRW
$17.5B
| $62.8M | 0.15% |
740,167
+3,300
| +0.4% | +$277K |
|
160
RingCentral
RNG
$5.28B
| $62.3M | 0.15% |
495,608
+75,400
| +18% | +$9.89M |
|
161
Booz Allen Hamilton
BAH
$9.15B
| $61.7M | 0.15% |
868,501
+329,600
| +61% | +$23.3M |
|
162
Southwest Airlines
LUV
$23B
| $61.4M | 0.15% |
1,137,000
+1,071,500
| +1,636% | +$56M |
|
163
Phillips 66
PSX
$81.4B
| $60.6M | 0.15% |
591,717
-767,600
| -56% | -$76.9M |
|
|
CTRA
164
DELISTED
Coterra Energy
CTRA
| $60.3M | 0.15% |
3,429,400
-2,001,400
| -37% | -$38.4M |
|
165
Quest Diagnostics
DGX
$26.3B
| $60.2M | 0.15% |
562,500
+26,704
| +5% | +$2.74M |
|
166
Alcoa
AA
$13.2B
| $59.5M | 0.15% |
2,963,004
-4,800
| -0.2% | -$99.8K |
|
167
Paycom
PAYC
$10B
| $59M | 0.14% |
281,500
+30,600
| +12% | +$7.15M |
|
168
CoStar Group
CSGP
$12.3B
| $58.9M | 0.14% |
992,330
+855,000
| +623% | +$51.2M |
|
169
Mohawk Industries
MHK
$9.22B
| $58.8M | 0.14% |
473,736
-415,100
| -47% | -$53.3M |
|
170
Royal Bank of Canada
RY
$293B
| $58.2M | 0.14% |
716,996
+127,100
| +22% | +$9.92M |
|
171
Republic Services
RSG
$66B
| $58.1M | 0.14% |
670,886
-276,700
| -29% | -$24.3M |
|
|
PFPT
172
DELISTED
Proofpoint, Inc.
PFPT
| $57.6M | 0.14% |
446,041
+29,800
| +7% | +$3.65M |
|
173
Best Buy
BBY
$17.3B
| $57.4M | 0.14% |
832,499
-166,202
| -17% | -$11.6M |
|
174
Kimberly-Clark
KMB
$36.5B
| $57.1M | 0.14% |
402,300
-51,700
| -11% | -$7.1M |
|
175
Edwards Lifesciences
EW
$51.7B
| $56.5M | 0.14% |
770,409
+34,800
| +5% | +$2.44M |
|
Similar funds
CWM
VRS
FAF
BGIM
CIM
PPFA
Two Sigma Advisers's Q3 2019 Portfolio in Review
As of Q3 2019, Two Sigma Advisers held 2,544 positions worth $40.9B, up 1.7% from $40.2B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Two Sigma Advisers deployed $1.28B of net new capital in Q3 2019, opening 250 new positions and adding to 806 existing holdings. Its largest new stake was State Street SPDR S&P 500 ETF Trust: 500,527 shares worth $149M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 17% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was Amgen, an estimated $317M trimmed.
- Two Sigma Advisers's largest Q3 2019 buy was State Street SPDR S&P 500 ETF Trust: 500,527 shares worth $149M.
- Two Sigma Advisers added most to Alphabet (Google) Class A in Q3 2019, an estimated $292M increase.
- Two Sigma Advisers's biggest Q3 2019 reduction was Amgen, cutting an estimated $317M.
- Two Sigma Advisers fully exited Red Hat Inc in Q3 2019, selling an estimated $137M.
- Two Sigma Advisers's ten largest holdings make up 12% of its $40.9B portfolio in Q3 2019.
- Two Sigma Advisers opened 250 new positions and closed 346 in Q3 2019.
- Two Sigma Advisers's portfolio value rose 1.7% quarter-over-quarter to $40.9B.
Based on Two Sigma Advisers's 13F filing for Q3 2019, filed 14 Nov 2019.